MedTrace Logo

Efficacy and Safety of Hemorrane Plus Versus Hemorrane and Versus Placebo in Patients With Uncomplicated Haemorrhoids

NCT05788497 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 21

Last updated 2024-02-28

No results posted yet for this study

Summary

This is a Multicentre, double-blind, randomised clinical trial to evaluate and compare the efficacy and safety of Hemorrane Plus (Hemorrane® + benzocaine) with Hemorrane® and with placebo in patients with uncomplicated haemorrhoids.

Conditions

  • Haemorrhoids Without Complication

Interventions

DRUG

Hemorrane plus

Hemorrane 10 mg/g rectal ointment + 30 mg/g benzocaine

DRUG

Hemorrane

Hemorrane 10 mg/g rectal ointment

DRUG

Placebo

Rectal ointment

Sponsors & Collaborators

  • Dynamic Science S.L.

    collaborator INDUSTRY

  • Faes Farma, S.A.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-30
Primary Completion
2024-01-04
Completion
2024-01-04

Countries

  • Spain

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05788497 on ClinicalTrials.gov